News

Researchers have discovered a simple method for identifying nanobodies with drug-like properties suitable for preventing SARS-CoV-2 infections.

University of Michigan researchers have found a simple method for identifying nanobodies with drug-like properties suitable for preventing SARS-CoV-2 infections.

A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people.

Scientists have developed an antibody conjugate that delivers drugs to bone tumors and inhibits metastasis.

The venom of a caterpillar, native to South East Queensland, shows promise for use in medicines and pest control, Institute for Molecular Bioscience researchers say.

Scientists have created antibody-drug conjugates that link a synthetic uncialamycin analogue to antibodies targeting cancer cells.

A research group has used gene editing technologies to show how targeting Hypoxia Inducible Factor-1 alpha can inhibit tumor growth and drive cytotoxic immune cells to the cancer tissue.

The investigational drugs gantenerumab and solanezumab – both monoclonal antibody (mAb) therapeutics – failed to slow cognitive decline in patients with dominantly inherited Alzheimer’s disease (DIAD), a new trial has found.

Researchers have built one of the most comprehensive catalogs of the human transcriptome ever.

Research demonstrates that reconstituted vaccines can be transported following minor precautions.